BRIEF-Sino Biopharmaceutical FY profit attributable HK$1.91 bln

March 13 (Reuters) - Sino Biopharmaceutical Ltd:

* FY profit attributable to equity holders HK$1.91 billion,

7.6% higher

* FY revenue HK$ 15.83 billion versus HK$14.55 billion

* Company recommended payment of a final dividend of HK1.5

cents per share for year ended 31 December, 2016

Source text for Eikon:

Further company coverage: